Literature DB >> 29162581

Maturation of CGM and Glycemic Measurements Beyond HbA1c-A Turning Point in Research and Clinical Decisions.

Matthew C Riddle1, Hertzel C Gerstein2, William T Cefalu3.   

Abstract

Year:  2017        PMID： 29162581     DOI： 10.2337/dci17-0049

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.

Authors:  Lalantha Leelarathna; Hood Thabit; Malgorzata E Wilinska; Lia Bally; Julia K Mader; Thomas R Pieber; Carsten Benesch; Sabine Arnolds; Terri Johnson; Lutz Heinemann; Norbert Hermanns; Mark L Evans; Roman Hovorka
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring.

Authors:  Pamela R Kushner; Davida F Kruger
Journal:  Clin Diabetes       Date:  2020-10

3.  Status of glycemic excursions and hypoglycemia in patients with type 1 diabetes 2 months after first initiation of intermittently scanned continuous glucose monitoring: a pilot study.

Authors:  Yuka Suganuma; Hiroshi Takahashi; Rimei Nishimura
Journal:  Diabetol Int       Date:  2022-05-23

4.  Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.

Authors:  Naru Babaya; Shinsuke Noso; Yoshihisa Hiromine; Yasunori Taketomo; Fumimaru Niwano; Sawa Yoshida; Sara Yasutake; Yumiko Kawabata; Hiroshi Ikegami
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

Review 5.  Time in range: a new parameter to evaluate blood glucose control in patients with diabetes.

Authors:  Monica Andrade Lima Gabbay; Melanie Rodacki; Luis Eduardo Calliari; Andre Gustavo Daher Vianna; Marcio Krakauer; Mauro Scharf Pinto; Janice Sepúlveda Reis; Marcia Puñales; Leonardo Garcia Miranda; Ana Claudia Ramalho; Denise Reis Franco; Hermelinda Pedrosa Cordeiro Pedrosa
Journal:  Diabetol Metab Syndr       Date:  2020-03-16       Impact factor: 3.320
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.